search
Back to results

Cornell University-Micronutrient Initiative Calcium Supplementation Study (MICA)

Primary Purpose

Preeclampsia

Status
Completed
Phase
Not Applicable
Locations
Kenya
Study Type
Interventional
Intervention
Regimen A calcium and iron/folic acid
Regimen B calcium and iron/folic acid
Sponsored by
Cornell University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Preeclampsia focused on measuring Adherence, Calcium supplementation, Prevention of preeclampsia, Adherence to calcium supplementation

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Attendance at ANC clinic in a primary care facility in Kakamega north

Exclusion Criteria:

  • Gestational age < 16 weeks,
  • Gestational age > 30 weeks,
  • Dietary or medicinal consumption of adequate calcium (according to the screening survey),
  • Intention to leave study community before 8weeks from date of interview

Sites / Locations

  • Chebwayi Health centre
  • Chegulo Health centre
  • Chevoso Health centre
  • Chimoi dispensary
  • Chombeli Health centre
  • Imbiakhalo Health centre
  • Kimangeti Health centre
  • Kuvasali Health centre
  • Malava district hospital
  • Manda Health centre
  • Miting'ongo Health centre
  • Mugai Health centre
  • Namagara Health centre
  • Shamberere Health centre
  • Shihome Health centre
  • Shivanga Health centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Regimen A

Regimen B

Arm Description

500mg elemental calcium (as CaCO3) + 200 microgram Vit D per administration, administered 2 times a day, at least 2hours apart with one administration of 60mg elemental iron (as FeSO4) at any time of the day

500mg elemental calcium (as CaCO3) + 200 microgram Vit D per administration, administered 3 times a day, at least 2hours apart with one administration of 60mg elemental iron (as FeSO4) at any time of the day

Outcomes

Primary Outcome Measures

Amount of calcium supplement ingested
This is the actual number of supplements ingested expressed as a percentage of the number of supplements expected to be ingested since the ANC consultation if 100% adherent to the current WHO recommendation. [Total number of calcium supplements consumed/(Number of days since last ANC consultation X 3)] X 100

Secondary Outcome Measures

Adherence to related recommendations
Adherence to other features of the WHO recommendation (taking supplements with food).
Motivation
Motivation scores extracted from the survey instrument administered at follow up.
Self-efficacy
Self-efficacy scores extracted from the survey instrument administered at follow up.
Satisfaction
Satisfaction scores extracted from the survey instrument administered at follow up.

Full Information

First Posted
September 5, 2014
Last Updated
July 26, 2016
Sponsor
Cornell University
Collaborators
Kenya Ministry of Health, University of Nairobi, Micronutrient Initiative
search

1. Study Identification

Unique Protocol Identification Number
NCT02238704
Brief Title
Cornell University-Micronutrient Initiative Calcium Supplementation Study
Acronym
MICA
Official Title
A Cluster-randomized, Non-inferiority Open-label Trial of the Impact of Supplementation Regimen on Consumption of Prenatal Calcium and Iron/Folic Acid Supplements and Adherence to Related Recommendations
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
September 2014 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cornell University
Collaborators
Kenya Ministry of Health, University of Nairobi, Micronutrient Initiative

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The World Health Organization (WHO) now recommends prenatal calcium supplementation for prevention of preeclampsia in populations with inadequate dietary intake. This study seeks to compare the effect of two dosing strategies on the amount of supplement ingested by pregnant women and adherence to related recommendations.
Detailed Description
This study is a non-inferiority trial that compares the effect of a dosing strategy involving lower overall dose and fewer administrations per day to the current WHO recommendation. The comparator arm, Regimen B, prescribes 3 doses per day (consistent with current WHO standard) and was found to be burdensome in qualitative studies. The experimental arm, Regimen A, prescribes 2 doses per day and has been associated with greater satisfaction. On face value Regimen A should result in 33% less amount of supplement ingested than Regimen B. However, we hypothesize that the difference in amount ingested, when rolled out in routine practice will be MUCH LESS than that BECAUSE THE LOWER DOSE REGIMEN RESULTS IN HIGHER LEVELS OF ADHERENCE. We hypothesize that THE DIFFERENCE IN AMOUNT CONSUMED WILL BE NEGLIGIBLE OR will not exceed 15%. Hence, we hypothesize that Regimen A is not inferior to Regimen B in terms of total amount of supplement ingested (within a 15% margin of inferiority).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preeclampsia
Keywords
Adherence, Calcium supplementation, Prevention of preeclampsia, Adherence to calcium supplementation

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1032 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Regimen A
Arm Type
Experimental
Arm Description
500mg elemental calcium (as CaCO3) + 200 microgram Vit D per administration, administered 2 times a day, at least 2hours apart with one administration of 60mg elemental iron (as FeSO4) at any time of the day
Arm Title
Regimen B
Arm Type
Active Comparator
Arm Description
500mg elemental calcium (as CaCO3) + 200 microgram Vit D per administration, administered 3 times a day, at least 2hours apart with one administration of 60mg elemental iron (as FeSO4) at any time of the day
Intervention Type
Dietary Supplement
Intervention Name(s)
Regimen A calcium and iron/folic acid
Intervention Description
Comparison of recommended administration schedule for calcium and iron/folic acid supplements in pregnant women
Intervention Type
Dietary Supplement
Intervention Name(s)
Regimen B calcium and iron/folic acid
Intervention Description
Comparison of recommended administration schedule for calcium and iron/folic acid supplements in pregnant women
Primary Outcome Measure Information:
Title
Amount of calcium supplement ingested
Description
This is the actual number of supplements ingested expressed as a percentage of the number of supplements expected to be ingested since the ANC consultation if 100% adherent to the current WHO recommendation. [Total number of calcium supplements consumed/(Number of days since last ANC consultation X 3)] X 100
Time Frame
8 weeks after ANC consultation, during which recruitment into the study occurred
Secondary Outcome Measure Information:
Title
Adherence to related recommendations
Description
Adherence to other features of the WHO recommendation (taking supplements with food).
Time Frame
8 weeks after ANC consultation, during which recruitment into the study occurred
Title
Motivation
Description
Motivation scores extracted from the survey instrument administered at follow up.
Time Frame
8 weeks after ANC consultation, during which recruitment into the study occurred
Title
Self-efficacy
Description
Self-efficacy scores extracted from the survey instrument administered at follow up.
Time Frame
8 weeks after ANC consultation, during which recruitment into the study occurred
Title
Satisfaction
Description
Satisfaction scores extracted from the survey instrument administered at follow up.
Time Frame
8 weeks after ANC consultation, during which recruitment into the study occurred

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Attendance at ANC clinic in a primary care facility in Kakamega north Exclusion Criteria: Gestational age < 16 weeks, Gestational age > 30 weeks, Dietary or medicinal consumption of adequate calcium (according to the screening survey), Intention to leave study community before 8weeks from date of interview
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katherine Dickin, PhD
Organizational Affiliation
Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chebwayi Health centre
City
Kakamega
Country
Kenya
Facility Name
Chegulo Health centre
City
Kakamega
Country
Kenya
Facility Name
Chevoso Health centre
City
Kakamega
Country
Kenya
Facility Name
Chimoi dispensary
City
Kakamega
Country
Kenya
Facility Name
Chombeli Health centre
City
Kakamega
Country
Kenya
Facility Name
Imbiakhalo Health centre
City
Kakamega
Country
Kenya
Facility Name
Kimangeti Health centre
City
Kakamega
Country
Kenya
Facility Name
Kuvasali Health centre
City
Kakamega
Country
Kenya
Facility Name
Malava district hospital
City
Kakamega
Country
Kenya
Facility Name
Manda Health centre
City
Kakamega
Country
Kenya
Facility Name
Miting'ongo Health centre
City
Kakamega
Country
Kenya
Facility Name
Mugai Health centre
City
Kakamega
Country
Kenya
Facility Name
Namagara Health centre
City
Kakamega
Country
Kenya
Facility Name
Shamberere Health centre
City
Kakamega
Country
Kenya
Facility Name
Shihome Health centre
City
Kakamega
Country
Kenya
Facility Name
Shivanga Health centre
City
Kakamega
Country
Kenya

12. IPD Sharing Statement

Citations:
PubMed Identifier
30402593
Citation
Martin SL, Wawire V, Ombunda H, Li T, Sklar K, Tzehaie H, Wong A, Pelto GH, Omotayo MO, Chapleau GM, Stoltzfus RJ, Dickin KL. Integrating Calcium Supplementation into Facility-Based Antenatal Care Services in Western Kenya: A Qualitative Process Evaluation to Identify Implementation Barriers and Facilitators. Curr Dev Nutr. 2018 Aug 23;2(11):nzy068. doi: 10.1093/cdn/nzy068. eCollection 2018 Nov.
Results Reference
derived
PubMed Identifier
28878035
Citation
Omotayo MO, Dickin KL, Pelletier DL, Mwanga EO, Kung'u JK, Stoltzfus RJ. A Simplified Regimen Compared with WHO Guidelines Decreases Antenatal Calcium Supplement Intake for Prevention of Preeclampsia in a Cluster-Randomized Noninferiority Trial in Rural Kenya. J Nutr. 2017 Oct;147(10):1986-1991. doi: 10.3945/jn.117.251926. Epub 2017 Sep 6.
Results Reference
derived
PubMed Identifier
28250195
Citation
Martin SL, Omotayo MO, Pelto GH, Chapleau GM, Stoltzfus RJ, Dickin KL. Adherence-Specific Social Support Enhances Adherence to Calcium Supplementation Regimens among Pregnant Women. J Nutr. 2017 Apr;147(4):688-696. doi: 10.3945/jn.116.242503. Epub 2017 Mar 1.
Results Reference
derived

Learn more about this trial

Cornell University-Micronutrient Initiative Calcium Supplementation Study

We'll reach out to this number within 24 hrs